| Parameter | AML group (with CD155 < 5.35) (N = 50) | AML group (with CD155 > 5.35) (N = 50) | P | |||
| Hb* | Mean ± SD | 8.24 ± 2.0 | 7.94 ± 2.20 | 0.484 | ||
| WBCS | Median | 27.0 | 21.0 | 0.492 | ||
| Min-Max | 1.0 | 63.0 | 1.0 | 95.0 | ||
| PLT | Median | 33.50 | 33.0 | 0.753 | ||
| Min-Max | 14.0 | 266.0 | 13.0 | 266.0 | ||
| LDH | Median | 88.0 | 770.0 | <0.001 | ||
| Min-Max | 60.0 | 920.0 | 256.0 | 970.0 | ||
| Blast in BM | Median | 60.0 | 80.0 | 0.076 | ||
| Min-Max | 20.0 | 90.0 | 20.0 | 90.0 | ||
| FLT3 | Positive | 12 | 31.5% | 26 | 68.5% | 0.002 |
| NPM | Positive | 40 | 71.5% | 16 | 28.5% | 0.001 |
| CD56 | Positive | 36 | 72.0% | 20 | 40.0% | 0.001 |
| CD16 | Positive | 34 | 68.0% | 20 | 40.0% | 0.005 |
| t (8; 21) (positive N/24) | Positive | 3 | 21.4% | 1 | 10.0% | 0.615 |
| Inver 16 (positive N/22) | Positive | 4 | 30.8% | 4 | 44.4% | 0.662 |
| 11q23 rearrangement (positive N/8) | Positive | 2 | 66.7% | 2 | 40.0% | 1.00 |
| t (15; 17) (positive N/14) | Positive | 10 | 90.9% | 3 | 100.0% | 1.00 |